Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential Interactions Between Truvada and Hormone Therapy
Conditions: HIV Prevention; Transgender Health Intervention: Drug: 200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate Sponsors: University of California, San Francisco; San Francisco AIDS Foundation; California HIV/AIDS Research Program Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials